Little Green Pharma has struck a $7.5 million take-or-pay deal with Four 20 Pharma, introducing its new high-THC cannabis strain into Germany. The company's largest single-strain off-take contract comes on the heels of its recent $9m offtake with vertically integrated...
Marine Biomedical is confident future regulatory approval of its patented bone replacement technology derived from material harvested from pearl farms will lead to a three to four-fold increase in the value of the novel Broome-based business. From its headquarters...
HSC Technology Group has received Therapeutic Goods Approval for selling the company's powerful CardiacSense heart-monitoring watch in Australia and New Zealand. The Australia/New Zealand first-of-its-kind device includes precise detection of atrial fibrillation by...
Australia's Little Green Pharma has signed a three-year deal with Sana Life Sciences, giving the UK-based virtual store distribution of its medical-grade cannabis products across the British Isles. Cash from sales is expected as soon as this quarter, with an...
Little Green Pharma will bank $9 million a year following its most significant off-take agreement with Germany's first independent and vertically integrated medical cannabis startup. Demecan will purchase 450 kilograms of high-quality THC flower strains with an eye on...
Health House International insurance provider agreements will now allow the Australian company to supply medicinal cannabis to over 35 million Germans or close to half of the country's insured patients. The framework agreements, granting the company preferred supplier...
Health House International will soon be acquired by Perth-based Zelira Therapeutics, creating a medicinal cannabis organisation with top-line products and extensive global reach. HHI says it is upbeat about the merger, which provides plenty of upsides viewing in-house...
HSC Technology Group has hit and surpassed a milestone for its Talius Smart Care platform, moving beyond 11 thousand subscribers while inking deals to advance the innovative service further. The innovator pushed its platform forward after it certified a national...
AHI has struck a deal with Activate Health expanding into the Northern European nation of Estonia, delivering the world’s first AI-driven digital therapeutics platform for treating metabolic syndrome, affecting more than 500,000 Australians and nearly a third of the...
